2016
DOI: 10.1016/s0140-6736(16)31326-5
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study

Abstract: . (2016) Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet, 388(10056), pp. 2142Lancet, 388(10056), pp. -2152Lancet, 388(10056), pp. . (doi:10.1016 This is the author's final accepted version.There may be differences between this version and the published version. You are advised to consult the publisher's version if you wish to cite from it.http://eprints.gla.ac.uk/12400… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

25
182
4
11

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 379 publications
(231 citation statements)
references
References 31 publications
25
182
4
11
Order By: Relevance
“…Individuals with known CAD and hypertension enrolled in the international verapamil-trandolapril study (INVEST) study and CLARIFY registries had increased risk of cardiovascular events and mortality when DBP < 60 mmHg. 3,22,23 In the current study, CAC > 0 among persons without known clinical CAD identified individuals at higher relative risk of CHD events and all-cause mortality when DBP < 60 mmHg. There was no association between low DBP and events among those without calcified coronary atherosclerosis; however, due to the moderate sample size we cannot rule out that these individuals may also be at risk (albeit of lower magnitude) from low DBP.…”
Section: Discussionmentioning
confidence: 51%
See 1 more Smart Citation
“…Individuals with known CAD and hypertension enrolled in the international verapamil-trandolapril study (INVEST) study and CLARIFY registries had increased risk of cardiovascular events and mortality when DBP < 60 mmHg. 3,22,23 In the current study, CAC > 0 among persons without known clinical CAD identified individuals at higher relative risk of CHD events and all-cause mortality when DBP < 60 mmHg. There was no association between low DBP and events among those without calcified coronary atherosclerosis; however, due to the moderate sample size we cannot rule out that these individuals may also be at risk (albeit of lower magnitude) from low DBP.…”
Section: Discussionmentioning
confidence: 51%
“…26 Recent data from the CLARIFY (Prospective observational longitudinal registry of patients with stable coronary artery disease) cohort suggest that this association is particularly strong among individuals with known coronary artery disease (CAD). 3 Presumably coronary perfusion distal to vessels with stenosis is impaired further by low DBP. While the association between low DBP and cardiac events is well established among adults with known clinical CAD, 6 little is known about the far larger demographic of persons with subclinical CAD (i.e., atherosclerotic coronary disease without prior clinical diagnosis).…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, intensive blood pressure control did improve outcomes among patients with type 2 diabetes in the ACCORD trial and in those with stroke, a nadir SBP of 120–128 mm Hg was associated with lower risk of adverse events(18, 22). We did not find effect modification of the observed associations by diabetes.…”
Section: Discussionmentioning
confidence: 95%
“…For instance, in a study that used registry clinical practice data from 45 countries that included patients with coronary artery disease and hypertension, SBP <120 mm Hg and DBP <70 mm Hg were associated with higher mortality(18). We found that deaths due to non-cardiovascular/non-malignancy causes were also higher with lower DBP and SBP levels.…”
Section: Discussionmentioning
confidence: 99%
“…Although diastolic BP (DBP) of <90 mm Hg is recommended in the current guidelines, studies using J curves have indicated that cardiovascular risk increases at <60 to 70 mm Hg 9, 10. Therefore, we also aimed to determine whether DBP lowering at <80 mm Hg was beneficial in poststroke hypertensive subjects.…”
Section: Methodsmentioning
confidence: 99%